Cancer Data Science Pulse

The Cancer Data Science Pulse blog provides insights on trends, policies, initiatives, and innovation in the data science and cancer research communities from professionals dedicated to building a national cancer data ecosystem that enables new discoveries and reduces the burden of cancer.

Allen Dearry, Ph.D., will retire from NCI’s CBIIT on December 31. Here Dr. Dearry reflects on his 31 years at NIH, including his role in helping to establish the Cancer Research Data Commons. He also offers advice for people just entering the field and describes what he’s planning to do next.

In this latest Data Science Seminar, Jim Lacey, Ph.D., M.P.H., shares the lessons he learned in transitioning a large cancer epidemiology cohort study to the cloud, including the importance of focusing on people and processes as well as technology. Project managers, principal investigators, co-investigators, data managers, data analysts—really anyone who is part of a team that wants to use the cloud or cloud-based resources for their studies—should attend.

The diversity, complexity, and distribution of data sets present an ongoing challenge to cancer researchers looking to perform advanced analyses. Here we describe the Cancer Genomics Cloud, powered by Seven Bridges, an NCI Cloud Resource that’s helping to bring together data and computational power to further advance cancer research and discovery.

Get to know David Kepplinger, Ph.D., who will present the next Data Science Seminar, “Robust Prediction of Stenosis from Protein Expression Data. ” In this Q&A, he describes who should attend the talk, how his topic relates to cancer, and why it’s important to delve into unexpected data values when conducting biostatistical analysis.

To commemorate the National Cancer Act’s 50th anniversary, we’ve pulled together Five Data Science Technologies poised to make a difference in how cancer is diagnosed, treated, and prevented.

On November 3, Dr. Duran will present the next Data Science Seminar, “Social Determinants of Health.” This blog offers insight into Dr. Duran’s work and why this topic is important to her.

Much of our current understanding of the microbiome’s role in cancer can be attributed to advances in DNA sequencing and data science. Here, we look at a key NCI-supported bioinformatics tool called QIIME 2, which is helping us better understand the microbiome and its impact on disease.

On Wednesday, September 22, 2021, Yanjun Qi, Ph.D., from the University of Virginia, will present “AttentiveChrome: Deep Learning for Predicting Gene Expression from Histone Modifications,” in the kickoff of the Fall Data Science Seminar Series. This blog offers insight on Dr. Qi’s research and why this topic is important to her.

Technological advancements, such as machine learning and artificial intelligence, have made open data sharing more complex and put new pressure on existing laws that protect data privacy. This blog examines the privacy processes and policies that are helping address privacy concerns in today’s ever-changing “big data” landscape.

CBIIT Director Dr. Tony Kerlavage loves data. He also loves to solve puzzles. In this blog, Dr. Kerlavage describes how advances in data and technology are helping us find solutions to some of today’s most pressing cancer-related questions. According to Dr. Kerlavage, there’s no problem too hard to solve and no question that we shouldn’t bother asking.